Eli Lilly & Co. (LLY): Will The Big Bets Pay Off?
Tomorrow, Eli Lilly & Co. (NYSE:LLY) will release its latest quarterly results.
Posts Tagged ‘NYSE:SNY’
Sanofi SA (ADR) (SNY), Johnson & Johnson (JNJ), and Investing in Potential Blockbusters
A popular drug that crosses a benchmark sale of $1 billion for the manufacturer is called a blockbuster drug.
Amgen, Inc. (AMGN), Regeneron Pharmaceuticals Inc (REGN), NPS Pharmaceuticals, Inc. (NPSP): Can These Biotechs Continue to Climb?
Two high-flying biotech stocks of late are NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) .
Bristol Myers Squibb Co. (BMY): Is This Company Destined for Greatness?
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Sanofi SA (ADR) (SNY), Aegerion Pharmaceuticals, Inc. (AEGR): ISIS Pharmaceuticals, Inc. (ISIS), Big Pharma’s Little Friend
Roche Holding Ltd. (ADR) (PINK:RHHBY) and ISIS Pharmaceuticals, Inc.
Sanofi SA (ADR) (SNY), Johnson & Johnson (JNJ), and Three Things Warren Buffett Likes About Healthcare
Warren Buffett knows what he likes -- and he gets what he likes.
Dendreon Corporation (DNDN), Bristol Myers Squibb Co. (BMY), Sanofi SA (ADR) (SNY), Vical Incorporated (VICL): Understanding Why Cancer Vaccines Fail
The immune system doesn't generally attack tumors on its own. Immune cells are designed to attack foreign invaders but leave the human cells alone.
Biogen Idec Inc. (BIIB), Sanofi SA (ADR) (SNY), Elan Corporation, plc (ADR) (ELN): The Greatest Thing Since Sliced Bread Has Arrived for MS Patients
Last November, I examined five experimental drugs that appeared as if they had all of the tools necessary to become life-changing blockbusters from a financial and quality of ...
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Will This Successful Spin-off Mean More Spin-offs in the Industry?
After a wildly successful IPO that raised over $2 billion, and valued the newly-created company at more than $12 billion, pharmaceutical giant Pfizer Inc.
Abbott Laboratories (ABT), Eli Lilly & Co. (LLY), Regeneron Pharmaceuticals Inc (REGN): Is Johnson & Johnson (JNJ) a Cash King?
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
This Metric Says You Are Smart to Sell Sanofi SA (ADR) (NYSE:SNY)
Sanofi SA (ADR) (NYSE:SNY) was in 45 hedge funds' portfolio at the end of the fourth quarter of 2012. SNY has experienced a decrease in hedge fund sentiment lately.
AstraZeneca plc (ADR) (AZN), Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK): Is It Worth Getting a Flu Shot? The Answer May Surprise You…
Every year, it appears that flu season starts earlier and earlier, and somehow, every year, the virus mutates into its "most virulent form ever." Sometimes it's a wonder we even...
Arena Pharmaceuticals, Inc. (ARNA) Faces Europe’s Obesity Opportunity: VIVUS Inc. (VVUS)
You can't find a hotter topic in health care than obesity.
How to Profit From Increasing Obesity: Sanofi SA (ADR) (SNY), Novo Nordisk A/S (ADR) (NVO), Covidien plc (COV)
Funnily enough, I think that long term investors should be investing in the long term.
Merrimack Pharmaceuticals Inc (MACK) May Be Right For Your Portfolio
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) may be the perfect biotech company for your speculative portfolio.
Better Health, an iPhone App Away: Sanofi SA (ADR) (SNY), Johnson & Johnson (JNJ)
An Apple a day might not keep the doctor away, but the company's AppStore carries several solutions for tracking health care on the go -- and pharmaceutical companies continue...
Is Bristol-Myers Squibb Co. (BMY) One of the Best Companies in America?
The Motley Fool recently published its list of The 25 Best Companies in America and while Bristol-Myers Squibb Co.
Is Merck & Co., Inc. (MRK) One of the Best Companies in America?
The Motley Fool recently whittled down 1,700 public companies to name its list of The 25 Best Companies in America. Merck & Co., Inc.
3 Humongous Health-Care Stocks This Week: Celgene Corporation (CELG), Celldex Therapeutics, Inc. (CLDX)
The Dow set an all-time high, but it still was up only 2% for the week. If you want returns to really get excited about, look no further than the health-care sector.
Pharmaceutical Winners And Losers In Early 2013: Johnson & Johnson (JNJ), Sanofi SA (ADR) (SNY), Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
Ultimately, that was the loss of those optimists. As value investors, we are not afraid of bad news as long as we get compensated by low valuations.
Analyst Roundtable: Any Surprises in Amarin Corporation plc (ADR) (AMRN)’s Fourth Quarter?
Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to discuss Amarin Corporation plc (ADR) (NASDAQ:AMRN) , a biotech that recently launched...
What Stocks Are in Buffett’s Annual Letter? – Wells Fargo & Co (WFC), The Procter & Gamble Company (PG)
Okay, Okay! Another ‘Warren Buffett buys this, Buffett buys that’ article.
Thinking Smaller Is Big for Big Pharma: Eli Lilly & Co. (LLY), Sanofi SA (ADR) (SNY), Bristol Myers Squibb Co. (BMY)
Do good things come in small packages for big pharma? Most of investors' attention is given to blockbuster drugs and drugs that have the potential to be blockbusters.
Johnson & Johnson (JNJ), Dendreon Corporation (DNDN) – Tackling Cancer: Prostate Cancer’s Biggest Current and Upcoming Players
As I commented last week, cancer statistics are both staggering and disappointing.
Can’t-Miss Health-Care Events This Week: GlaxoSmithKline plc (ADR)(GSK), Theravance Inc (THRX)
On Monday, Depomed Inc (NASDAQ:DEPO) is expected to go before the FDA panel with its menopausal hot-flash drug, Serada.
Who’s the Frailest Big Pharma of All? – Bristol Myers Squibb Co. (BMY), Pfizer Inc. (PFE), Sanofi SA (ADR) (SNY)
Mirror, mirror, on the wall, who's the frailest big pharma of all? The patent cliff has certainly taken its toll over the past couple of years, weakening several successful pharmaceutical...
How Novo Nordisk A/S (ADR) (NVO) Will Deal With A Diabetes Delay: Sanofi SA (ADR) (SNY), Johnson & Johnson (JNJ)
Novo Nordisk A/S (ADR) (NYSE:NVO) recently got some bad news from the Food and Drug Administration: a request for additional information about a key insulin product.
Battle of the Pharma Dividends: Bristol Myers Squibb Co. (BMY) vs. Eli Lilly & Co. (LLY)
Are Bristol Myers Squibb Co. (NYSE:BMY) and Eli Lilly & Co.
Novo Nordisk A/S (ADR) (NVO): Still a Buy, Despite the Tresiba Setback
Shares of Novo Nordisk A/S (NYSE:NVO) are trying to recover from a recent sell-off that occurred after the FDA rejected its new drug Tresiba -- citing lack of a pre-approval ...
Merck & Co., Inc. (MRK): A Global Health Care Giant Doling Out a Massive Dividend
A SWOT analysis is a look at a company’s strengths, weaknesses, opportunities, and threats, and is a tremendous way to gain a detailed and thorough perspective on a company ...
4 Orphan Drugs Making Waves in 2013: Sanofi SA (ADR) (SNY) and More
Orphan drugs -- medications meant for small patient populations with rare, dangerous diseases -- can be a rewarding business for biotech firms that strike gold.
Sanofi SA (ADR) (SNY)’s GLP-1 Accepted for Review by FDA
Sanofi SA (ADR) (NYSE:SNY) announced this week that the Food and Drug Administration began to review the company's once-daily type 2 diabetes injectable lixisenatide.
Are These 3 Stocks Down for the Count?: Ruckus Wireless Inc (RKUS) and More
Horse meat and Wal-Mart Stores, Inc.
Can Johnson & Johnson (JNJ)’s Zytiga Build on a Historic 2012?
Johnson & Johnson (NYSE:JNJ) may offer well-known personal-care products such as Listerine and Neutrogena, but it also boasts an impressive portfolio of market-leading therapeutic...
Biogen Idec Inc. (BIIB): A Strong Growth Opportunity In Multiple Sclerosis
Biogen Idec Inc.(NASDAQ:BIIB) has just moved to reinforce its dominance in the multiple sclerosis treatment market by striking a deal to buy the 50% rights to Tysabri that it...
BioMarin Pharmaceutical Inc. (BMRN) Earnings: An Early Look
Earnings season is now starting to wind down, with most companies already having reported their quarterly results.
Pfizer Inc. (PFE) and More: Should Big Pharma Follow the Spinoff Trend?
Pfizer Inc. (NYSE:PFE) faced a rough 2012 after Lipitor's loss of exclusivity in November 2011.
BioMarin Pharmaceutical Inc. (BMRN) is a Prime Takeover Target
How many of us as investors want to identify companies that are pioneers in their industry? Is it possible to find commonality across sectors, which factors make specific companies...
Better Buy: Pfizer Inc. (PFE) or Zoetis Inc (ZTS)?
Pfizer Inc. (NYSE:PFE) recently spun off animal health firm Zoetis Inc (NYSE:ZTS) in the form of an IPO.
Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Rule This Multibillion-Dollar Market?
Back in 2011, generic drug giant Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) dominated the MS field, riding the coattails of its Copaxone medication to success.
Merck & Co., Inc. (MRK)’s Crash of a Titan
Merck & Co., Inc. (NYSE:MRK)'s blockbuster asthma and allergy treatment Singulair fell off patent last year -- wiping more than 60% of revenue off the company's top line.
Warren Buffett’s Long-Term Dividend Holds: Sanofi SA (ADR) (SNY) and More
Warren Buffett has made a name for himself by snatching up companies at deep discounts and holding until he’s captured as much value as possible.
Can These 3 Stocks Be Resurrected?: Heckmann Corporation (HEK) and More
Lackluster trading was being blamed for the Dow Jones Industrial Average ticking down 21 points yesterday, gripped by ennui over both domestic and international financial woes...
What’s Moving These Biotech Stocks? – Novo Nordisk (NVO), Peregrine Pharmaceuticals (PPHM)
Typically, it doesn't take a lot for a stock to trade with gains/losses of more than 5% in a session; it can be caused by an analyst's remarks, sometimes it's caused by earnings...
We Love You, Just Not Enough to Buy You (Yet): Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (SNY)
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) said Monday that it got a notice from its partner Sanofi SA (NYSE:SNY) saying that the pharma intends to buy additional shares of the...
The Best Dividend in Big Pharma: Sanofi SA (SNY), Pfizer Inc. (PFE), GlaxoSmithKline plc (GSK)
Big pharma's a good place to start if you're looking for dividend stocks.
Xerenex Kidney Treatment: A Game Changer for Keryx Biopharmaceuticals (KERX)
Keryx Biopharmaceuticals (NASDAQ:KERX)’s latest kidney drug called Zerenex is a game changer for the company after achieving positive results from its long-term Phase 3 study...
The Investor’s Guide to Zoetis Inc (ZTS): Pfizer Inc. (PFE), Merck & Co., Inc. (MRK)
Looking for the hottest name in health care? Right now it's not big pharma nor even a hot biotech firm making waves on Wall Street; it's newly minted animal health firm Zoetis...
High Dividend Yields for Billionaire Thomas Steyer’s Farallon Capital
Since founding Farallon Capital Management in 1986, Thomas Steyer and fellow investment manager Andrew J. M.
